These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 29197543)

  • 21. Characterization of binge-dosed methamphetamine-induced neurotoxicity and neuroinflammation.
    McConnell SE; O'Banion MK; Cory-Slechta DA; Olschowka JA; Opanashuk LA
    Neurotoxicology; 2015 Sep; 50():131-41. PubMed ID: 26283213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonists of the neurokinin-1 or dopamine D1 receptors confer protection from methamphetamine on dopamine terminals of the mouse striatum.
    Angulo JA; Angulo N; Yu J
    Ann N Y Acad Sci; 2004 Oct; 1025():171-80. PubMed ID: 15542715
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A recent trend in methamphetamine-induced neurotoxicity].
    Kita T; Nakashima T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2002 Apr; 22(2):35-47. PubMed ID: 12050851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine D1 receptors mediate methamphetamine-induced dopaminergic damage: involvement of autophagy regulation via the AMPK/FOXO3A pathway.
    He T; Han C; Liu C; Chen J; Yang H; Zheng L; Waddington JL; Zhen X
    Psychopharmacology (Berl); 2022 Mar; 239(3):951-964. PubMed ID: 35190859
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of dopamine D1- and D2-like receptor mechanisms in drug-seeking following methamphetamine self-administration in rats.
    Carati C; Schenk S
    Pharmacol Biochem Behav; 2011 May; 98(3):449-54. PubMed ID: 21334368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein kinase Cδ mediates methamphetamine-induced dopaminergic neurotoxicity in mice via activation of microsomal epoxide hydrolase.
    Shin EJ; Jeong JH; Sharma G; Sharma N; Kim DJ; Pham DT; Trinh QD; Dang DK; Nah SY; Bing G; Kim HC
    Food Chem Toxicol; 2019 Nov; 133():110761. PubMed ID: 31422080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the role of dopamine in the differential neurotoxicity patterns of methamphetamine, mephedrone, methcathinone and 4-methylmethamphetamine.
    Anneken JH; Angoa-Perez M; Sati GC; Crich D; Kuhn DM
    Neuropharmacology; 2018 May; 134(Pt A):46-56. PubMed ID: 28851615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D(1) receptor deletion strongly reduces neurotoxic effects of methamphetamine.
    Ares-Santos S; Granado N; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
    Neurobiol Dis; 2012 Feb; 45(2):810-20. PubMed ID: 22115942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKCδ-dependent p47phox activation mediates methamphetamine-induced dopaminergic neurotoxicity.
    Dang DK; Shin EJ; Kim DJ; Tran HQ; Jeong JH; Jang CG; Ottersen OP; Nah SY; Hong JS; Nabeshima T; Kim HC
    Free Radic Biol Med; 2018 Feb; 115():318-337. PubMed ID: 29269308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of methamphetamine-induced neurotoxicity on striatal long-term potentiation.
    Gibson AS; West PJ; Keefe KA
    Psychopharmacology (Berl); 2022 Jan; 239(1):93-104. PubMed ID: 34985532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current research on methamphetamine-induced neurotoxicity: animal models of monoamine disruption.
    Kita T; Wagner GC; Nakashima T
    J Pharmacol Sci; 2003 Jul; 92(3):178-95. PubMed ID: 12890883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological assessment of methamphetamine-induced behavioral hyperactivity mediated by dopaminergic transmission in planarian Dugesia japonica.
    Tashiro N; Nishimura K; Daido K; Oka T; Todo M; Toshikawa A; Tsushima J; Takata K; Ashihara E; Yoshimoto K; Agata K; Kitamura Y
    Biochem Biophys Res Commun; 2014 Jul; 449(4):412-8. PubMed ID: 24858686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKCδ knockout mice are protected from para-methoxymethamphetamine-induced mitochondrial stress and associated neurotoxicity in the striatum of mice.
    Shin EJ; Dang DK; Tran HQ; Nam Y; Jeong JH; Lee YH; Park KT; Lee YS; Jang CG; Hong JS; Nabeshima T; Kim HC
    Neurochem Int; 2016 Nov; 100():146-158. PubMed ID: 27623093
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Experimental study of methamphetamine psychosis--role of glutamate and nitric oxide in methamphetamine-induced dopaminergic and serotonergic neurotoxicity in the rat brain].
    Abekawa T
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):113-26. PubMed ID: 9086367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents.
    Kim YJ; Ma SX; Hur KH; Lee Y; Ko YH; Lee BR; Kim SK; Sung SJ; Kim KM; Kim HC; Lee SY; Jang CG
    Arch Toxicol; 2021 Apr; 95(4):1413-1429. PubMed ID: 33515270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The potent psychomotor, rewarding and reinforcing properties of 3-fluoromethamphetamine in rodents.
    Ryu IS; Yoon SS; Choi MJ; Lee YE; Kim JS; Kim WH; Cheong JH; Kim HJ; Jang CG; Lee YS; Steffensen SC; Ka M; Woo DH; Jang EY; Seo JW
    Addict Biol; 2020 Nov; 25(6):e12846. PubMed ID: 31797481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D1 and D2 dopaminergic systems in the rat basolateral amygdala are involved in anxiogenic-like effects induced by histamine.
    Bananej M; Karimi-Sori A; Zarrindast MR; Ahmadi S
    J Psychopharmacol; 2012 Apr; 26(4):564-74. PubMed ID: 21628344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine administration causes death of dopaminergic neurons in the mouse olfactory bulb.
    Deng X; Ladenheim B; Jayanthi S; Cadet JL
    Biol Psychiatry; 2007 Jun; 61(11):1235-43. PubMed ID: 17161385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resistance of neuronal nitric oxide synthase-deficient mice to methamphetamine-induced dopaminergic neurotoxicity.
    Itzhak Y; Gandia C; Huang PL; Ali SF
    J Pharmacol Exp Ther; 1998 Mar; 284(3):1040-7. PubMed ID: 9495865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.